Diageo에 대한 매도 수량은 투자자에게 Diageo의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Diageo (NYSE:DEO) 주식, 공매도 수량 보고

Diageo

Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio. The firm has also shed noncore brands over the years, including the majority of its wine assets in 2015.

News

Movers

주요 주류 생산업체와 유통업체들의 주식은 미국 공중보건국장인 비벡 머시(Vivek Murthy)가 알코올 소비와 관련된 암 위험 증가에 대해 경고한 후 금요일 급락했다. 

금요일 미국 주류 주식이 하락 마감: 무슨 일이?

Entertainment

IPOs

FWONA

FWONK

TMUS

배우 라이언 레이놀즈를 최고 크리에이티브 책임자(CCO)로 둔 한 마케팅 회사는 2025년 기업공개를 계획하고 있으며, 대형 스크린에서 &#39;데드풀&#39;을 연기한 것으로 가장 잘 알려진 이 배우의 최근 성공 사례를 추가할 예정이다.

라이언 레이놀즈의 10억 달러 행진, 그의 바이럴 마케팅 회사가 다음에 상장될 것인가?

Education

Entrepreneurship

Success Stories

배우 라이언 레이놀즈는 요즘 극장가에서 데드풀(Deadpool) 역할로 가장 잘 알려져 있다. 이 역할은 현재 극장에서 상영 중인 세 번째 프랜차이즈 영화로 거대 미디어인 월트 디즈니 컴퍼니(NYSE:DIS)의 기록을 세우는 역할이다.

라이언 레이놀즈는 데드풀로 박스오피스를 장악하는 동시에 수십억 달러 규모의 사업을 구축

Diageo PLC

Deoleo SA

Beer and spirits maker Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) has said that it is selling its 80.4% stake in Guinness Ghana Breweries plc to Castel Group, deepening its ongoing <a target="_blank" href="https://www.diageo.com/en/news-and-media/press-releases/2025/diageo-plc-sells-its-shareholding-in-guinness-ghana-breweries-plc-to-castel-group-for-81-million" rel="noreferrer noopener">collaboration with the African multinational</a>.
Although this sale takes place, Diageo will still hold the rights to the renowned Guinness brand, along with other products it currently manufactures at the brewery.
These items will remain in production under a new long-term licensing and royalty arrangement, according to Diageo.
The company will continue to oversee the marketing and strategy for the Guinness brand in partnership with Castel.
This arrangement will enable Diageo to retain control over the brand&#8217;s direction while leveraging Castel&#8217;s regional expertise. The collaboration with Castel spans 11 additional African markets, where the companies already work together.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43275406/mattel-launches-new-building-sets-brand-brick-shop" rel="noreferrer noopener">Mattel Unveils New Brand In Building Sets Category &#8211; What&#8217;s On The Blocks?</a>
&#8220;Guinness Ghana is performing strongly powered by a fantastic team of people. Through this transaction, I look forward to the Guinness brand continuing to thrive and delivering further growth,&#8221; said President Diageo Africa and Chief Commercial Officer Dayalan Nayager.
All Diageo brands currently produced by Guinness Ghana, including Guinness, Malta, Orijin, Smirnoff Ice and Alvaro, and mainstream spririts, will continue to be produced under new license and royalty agreements.
This move supports Diageo&#8217;s asset-light business model, which emphasizes tailoring market approaches to local conditions in order to boost profitability.
This transaction is part of Diageo&#8217;s ongoing efforts to manage its portfolio, building on the recent sale of its stake in Guinness Nigeria and other strategic actions designed to accelerate growth in West Africa.
Price Action: DEO shares are trading lower by 0.87% at $122.46 in premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43260771/pillsbury-maker-general-mills-adjusts-fiscal-2025-earnings-after-yogurt-divestiture" target="_blank" rel="noreferrer noopener">Pillsbury Maker General Mills Adjusts Fiscal 2025 Earnings Outlook After Canadian Yogurt Divestiture: Details</a></li>
</ul>
Photo via Shutterstock.

Equities

Asset Sales

General

Alcohol Giant Diageo Sells Majority Stake In Guinness Ghana For $81 Million

WIIM

Diageo shares are trading higher after the company announced they will review their drinks portfolio to reignite growth.

<a href="https://www.bloomberg.com/news/articles/2025-01-24/diageo-is-said-to-review-drinks-portfolio-to-reignite-growth?sref=2h1zKciy" title="https://www.bloomberg.com/news/articles/2025-01-24/diageo-is-said-to-review-drinks-portfolio-to-reignite-growth?sref=2h1zKciy">https://www.bloomberg.com/news/articles/2025-01-24/diageo-is-said-to-review-drinks-portfolio-to-reignite-growth?sref=2h1zKciy</a>

Management

'Diageo Is Said To Review Drinks Portfolio To Reignite Growth; Spirits Maker Seen Likely To Reduce Medium-Term Guidance; Diageo Weighing Options For $10B Guinness Brand' - Bloomberg News

TD Cowen maintains Diageo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) with a Hold and raises the price target from $124 to $129.

Price Target

Analyst Ratings

TD Cowen Maintains Hold on Diageo, Raises Price Target to $129

Shares of major alcohol producers and distributors declined sharply Friday following a warning issued by U.S. Surgeon General Vivek Murthy about the increased cancer risks <a href="https://www.benzinga.com/government/regulations/25/01/42787400/alcohol-increases-cancer-risk-surgeon-general-warns">associated with alcohol consumption.</a>
What To Know: Murthy&#8217;s advisory emphasized the need for updated health warning labels to reflect mounting evidence of alcohol&#8217;s connection to cancer. These labels have not been revised since 1988. The advisory also called for reassessing recommended alcohol consumption limits, highlighting alcohol's role as the third-leading preventable cause of cancer in the United States, behind tobacco and obesity.
Murthy&#8217;s statement drew attention to alcohol&#8217;s association with at least seven types of cancer, including breast, liver and colorectal cancers. He pointed out that alcohol consumption contributes to approximately 100,000 cancer cases and 20,000 deaths annually in the United States. The announcement highlighted that only 45% of American adults are aware of the cancer risks posed by alcohol.
Stocks of leading alcohol companies reacted negatively to the news. 
Molson Coors Beverage Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) saw its shares drop by 3.72%, while Boston Beer Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4.26%. Anheuser-Busch InBev Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>)&#8217;s stock declined by 1.84% and Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) saw a 1.5% decrease. Diageo Inc.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) stock also traded lower, falling 3.15%. Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>), the maker of Jack Daniel&#8217;s whiskey, experienced a 2.58% decline.
The Surgeon General's advisory reignited discussions about public health measures and the potential for new regulations requiring updated warning labels on alcohol products. 
Price Action: Molson Coors shares were down 3.25% at $55.27, Boston Beer shares were down 3% at $292.60 and Anheuser-Busch shares were down 1.85% at $49 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro.</a>
Image Via Shutterstock.

Alcohol Stocks Are Falling Today: What's Going On?

Fomento Economico Mexicano S.A.B. De C.V.

Shares of alcohol stocks are trading lower after US Surgeon General Murthy issued an advisory warning alcohol consumption could raise cancer risk.

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Friday.
Shares of United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) fell sharply in <a href="https://www.benzinga.com/markets/equities/25/01/42779827/joe-biden-to-decide-on-nippon-steels-14-9b-us-steel-acquisition-on-friday-amid-veto-offer-labor-concerns">today's pre-market trading</a>.
This decline comes as President Joe Biden is poised to block the proposed acquisition by Nippon Steel (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NPSCY#OTC">NPSCY</a>), potentially as soon as Friday, Reuters reported, citing a source familiar with the matter.
United States Steel shares dipped 7.3% to $30.23 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Tejon Ranch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRC#NYSE">TRC</a>) shares dipped 11.4% to $14.01 in pre-market trading.</li>
<li>Lincoln Educational Services Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) shares fell 7.7% to $14.10 in pre-market trading after falling over 3% on Thursday.</li>
<li>Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) fell 4.6% to $15.39 in pre-market trading after jumping over 16% on Thursday.</li>
<li>Enhabit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) fell 4.5% to $7.40 in pre-market trading.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 2.9% to $122.58 in pre-market trading.</li>
<li>Nabors Energy Transition Corp. II (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NETD#NASDAQ">NETD</a>) fell 2.8% to $10.51 in pre-market trading.</li>
<li>Metallus Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTUS#NYSE">MTUS</a>) 2.8% to $13.31 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42763645/how-to-earn-500-a-month-from-acuity-brands-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

EHAB

HSAI

LINC

MTUS

NETD

NPSCY

United States Steel, Diageo And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Macro Economic Events

Politics

Economics

Reuters Reported Trump's Mexican Tariff Plan Could Hit U.S. Tequila Imports From Diageo, Becle Worth $3+B Combined In 2023

Donald Trump&#8216;s 2024 presidential election win put several sectors in the spotlight, <a href="https://www.benzinga.com/topic/alcohol">including alcohol stocks.</a>
What Happened: Some people watched the outcome of <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">election night</a> on television from their home. Others likely scrolled along with social media on their phone. Some attended watch parties with friends and families, similar to a Super Bowl party or one for <a href="https://www.benzinga.com/top-stories/24/08/40610039/are-nvidia-earnings-wall-streets-super-bowl-super-bulls-arrange-watch-parties-in-new-york-city">Nvidia's quarterly earnings.</a> 
Regardless of who voters wanted to win — Trump or Kamala Harris — they may have bought more alcohol for Election Day this year, at least in New York, with liquor stores reporting a busy day.
One liquor store <a href="https://nypost.com/2024/11/06/us-news/nyc-liquor-stores-were-crazy-busy-on-election-night-workers-say-weve-been-spending-hours-just-restocking/">told </a>the New York Post they were three to four times busier than a regular weekday on Election Day with heavy sales coming in the early afternoon and around 5 p.m. ET. An employee from Brooklyn's Juice Box liquor store told the Post there was also a noticeable trend from many customers.
"People were buying sparkling wine and a bottle of liquor for both (outcomes)," the employee said.
Employees from other New York stores noticed the same trend. Customers were either buying one type of alcohol for a happy outcome or one for a negative outcome.
"I have no idea if people will be drowning their sorrows or celebrating," the Juice Box employee added.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: While it is only one day of the year, Election Day 2024 could provide a short bump for alcohol stocks like Diageo Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) and Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>). Beer stocks like Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>), Boston Beer Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) and Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) may have also benefitted from Election Day.
Alcohol may be a coping or celebratory item for Election Day in the U.S., but in India the country <a href="https://timesofindia.indiatimes.com/world/us/us-election-2024-does-america-have-dry-days-like-india-during-election-season/articleshow/114945854.cms">has </a>dry days of no alcohol around their elections with residents unable to drink for 48 hours before the vote, on election day or as the vote is being totaled.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41817245/will-trump-be-sentenced-in-hush-money-trial-or-will-his-criminal-problems-go-away">Will Trump Be Sentenced In Hush Money Trial Or Will His &#8216;Criminal Problems Go Away&#8217;?</a></li>
</ul>
Image: Shutterstock

Alcohol Stocks To Get A Boost From 2024 Election? Busy Liquor Stores Say Voters 'Drowning Their Sorrows Or Celebrating'

<ul>
<li>Nikola trucks to be the first Class 8 hydrogen fuel cell electric vehicles operated day-to-day in the state of Illinois</li>
</ul>

NKLA

DHL Supply Chain And Diageo To Incorporate Two Fuel Cell Electric Trucks; Class 8 Trucks Manufactured By Nikola Will Be Deployed With HYLA Modular Refueler At Diago Campus

Constellation Brands (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stz#NYSE">STZ</a>) issued a mixed August quarter results lasy week, posting better than expected earnings as it continues to navigate a tough market.
<h3>Highlights Of The Second Quarter Of Fiscal 2025</h3>
Fueled by strong demand for its beer brands, especially Corona and Modelo, Constellation&nbsp;Brands reported net sales grew by 3% YoY to $2.92 billion.
Sales revenues increased by 6%&nbsp;while shipments&nbsp;grew by 4.6%.
Having already issued an alarm for its declining wines and spirits business whose sales dropped 12% to&nbsp;$388.7 million, Constellation reported a $2.5 billion write down. Wine and spirits were dragged down by a&nbsp;9.8% drop in shipment volumes.&nbsp;The division&rsquo;s operating income contracted 13% YoY to&nbsp;$70.5 million.
For the quarter ended on August 31st,&nbsp;adjusted earnings per share amounted to $4.32, surpassing&nbsp;LSEG&rsquo;s average estimate of $4.08.
Constellation can rely on its beer brands.
Beers have been the driver of Constellations&rsquo; success even before the pandemic lockdowns. Even in the post-pandemic era, consumers are turning to them, but doing so, they are also&nbsp;leaving behind wines and spirits. The latest quarter shows that Constellation continues to benefit from premium prices. While the industry continues being cautious in an uncertain macroeconomic environment, Constellation&rsquo;s beers were the biggest gainers for the twelfth successive quarter.
Yet, demand for spirits continues to fall.&nbsp;
But CEO Bill Newlands admitted the challenging macroeconomic backdrop has weighed on demand for beverage alcohol. Constellation gudied for full-year net sales growth between 4% and 6%, while expecting beer sales to go up from 6% to 8% and wine and spirits sales dropping 4% to 6%.
On the other hand, the wner of Guiness and Johnnie Walker, Diageo, is optimistic about spirits growth returning in the future. Diageo CEO Debra Crew believes that alcohol sales growth will return with the improving consumer environment. There&rsquo;s also increasing support from A list celebrities who are lending their influence to liquor brands. Among celebrities helping liquor brands become big businesses are Matthew McConaghew launched an organic tequilla brand, while Ryan Reynlods became a co-owner of Aviation Gin that was scooped up by Diageo in 2020, with George Clooney leading the way back in 2013 by co-founding Casamigos Tequilla, that was also sold to Diageo. But the reality is that Diageo plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/deo#NYSE">DEO</a>) posted bleak quarterly results in September, reflecting a weak macroenvironment in North America. After another lacluster quarter for wine and spirits, Constellation is expecting a &lsquo;sequential&rsquo; improvement over the second half of fiscal 2025.&nbsp;
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Constellation Brands' Latest Quarter Shows Wine And Spirits Business Continue To Fall From Glory

A marketing company that counts actor Ryan Reynolds as its chief creative officer plans to go public in 2025, adding to the recent success stories for the actor best known for playing "Deadpool"<a href="https://www.benzinga.com/general/entertainment/24/09/40737439/ryan-reynolds-dominates-box-office-as-deadpool-while-also-building-billion-dollar-businesse"> on the big screen.</a>
What Happened: Connected TV advertising company MNTN, is the owner of the <a href="https://www.benzinga.com/general/entertainment/23/07/33427835/ryan-reynolds-is-bringing-a-popular-television-alien-back-to-screens-hide-your-cats">Maximum Effort marketing segment</a> co-founded by Reynolds and George Dewey in 2018.
Known best for its advertisements to promote "Deadpool" and other viral advertisements for companies connected to Reynolds, Maximum Effort Marketing was bought out by MNTN in 2021.
MNTN is eyeing a 2025 IPO according to a new report from <a href="https://www.bloomberg.com/news/articles/2024-09-27/ryan-reynolds-s-mntn-is-said-to-tap-morgan-stanley-for-2025-ipo?sref=TBDibEcD">Bloomberg</a>, with Morgan Stanley set to work on the public offering.
The connected TV advertising company raised $119 million in a Series D round in 2021 with BlackRock Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) and Fidelity Management leading the round with $110 million invested together.
The Maximum Effort name comes from a catchphrase of Reynolds' Deadpool character. A separate Maximum Effort Productions company was not included in the sale to MNTN and is not part of the IPO. Dewey serves as the chief brand officer at Maximum Effort Marketing.
The marketing company from Reynolds has made ads for companies like Aviation Gin and Mint Mobile, which are connected to the actor. The company also made a well-known ad for dating company Match.com that <a href="https://www.youtube.com/watch?v=KABSYzPqTTg">featured </a>Satan and marked the debut of Taylor Swift's re-recording of the hit song "Love Story."
"I genuinely love marketing and I have been gobsmacked by how much fun it has been and how fast we have grown. We wanted a future for our marketing arm that ensured we could continue to move fast, have fun and do really rewarding work," Reynolds said at the time of MNTN's acquisition.
Reynolds said MNTN's simplicity, speech and ability to open up access to TV for advertisers who can't pay for upfront agreements stood out.
"I believe the combination of our companies will create a 1+1 equals 3 situation, assuming my math checks out," Reynolds added at the time.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: In a world of connected TV and viral advertisements that have to be quick and catchy, MNTN could stand out in a crowded field. The company's involvement in Reynolds and connection to several of his companies and movies could also help power growth in the coming years.
Aside from Maximum Effort Marketing and MNTN, Reynolds has built up several companies that are part of his success story away from the big screen.
The actor was a <a href="https://www.benzinga.com/m-a/23/03/31362824/ryan-reynolds-mobile-company-gets-1-35b-buyout-from-t-mobile-will-he-purchase-an-nhl-team-with-that">co-owner in Mint Mobile, </a>which was sold to T-Mobile US Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NYSE">TMUS</a>) at a $1.35 billion valuation. Reynolds had a stake in Aviation Gian, which was sold to Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) for $610 million in 2020.
Reynolds is also a<a href="https://www.benzinga.com/general/entertainment/24/04/38530584/ryan-reynolds-rob-mcelhenney-buy-another-soccer-team-can-dynamic-duo-turn-around-mexico-clu"> co-owner in soccer team</a> Wrexham AFC, owns a stake in Mexican soccer team Necaxa, and owns a stake in a Liberty Media Corporation Formula 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) racing team. The actor was also among the previously interested parties in buying the Ottawa Senators NHL team.
While it is unknown if Reynolds owns a stake in MNTN, the IPO likely comes thanks in part to the success of Maximum Effort Marketing in recent years. The IPO could further illustrate the success Reynolds has had outside of acting.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photo: Shutterstock

Ryan Reynolds' Billion-Dollar Streak: Will His Viral Marketing Firm Go Public Next?

<a href="https://www.diageo.com/en/news-and-media/press-releases/2024/diageo-expands-leading-position-in-non-alc-spirits-with-acquisition-of-ritual-zero-proof" title="https://www.diageo.com/en/news-and-media/press-releases/2024/diageo-expands-leading-position-in-non-alc-spirits-with-acquisition-of-ritual-zero-proof">https://www.diageo.com/en/news-and-media/press-releases/2024/diageo-expands-leading-position-in-non-alc-spirits-with-acquisition-of-ritual-zero-proof</a>

Diageo North America Acquires Ritual Zero Proof Non-Alcoholic Spirits; Deal Has Been Funded Through Existing Cash Resources; Exact Financial Terms Not Disclosed

Actor Ryan Reynolds is best-known these days for his role as Deadpool on the big screen, a role that is setting records for media giant The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a third franchise film <a href="https://www.benzinga.com/general/entertainment/24/07/40003208/ryan-reynolds-hugh-jackman-starrer-deadpool-wolverine-breaks-box-office-records-rakes-in-ov">currently in theaters. </a>
&#8220;Deadpool &amp; Wolverine&#8221; has grossed $582.7 million domestically and $634.8 billion internationally for a global total of $1.22 billion at the time of writing.
The film has set many records, including several for an &#8220;R&#8221; rated film, along with boosting Disney&#8217;s box office success for the 2024 year. 
While he&#8217;s known for his role as Deadpool, aka the &#8220;merc with the mouth,&#8221; Reynolds is also known for his investing and entrepreneurship thanks to a series of billion-dollar companies. 
Building Companies:&nbsp;A thread on X, formerly known as Twitter, about&nbsp;<a href="https://www.benzinga.com/topic/ryan-reynolds" target="_blank" rel="noreferrer noopener">Ryan Reynolds</a>&nbsp;highlights that he may be the &#8220;GOD of billion dollar brands.&#8221;
The&nbsp;<a href="https://twitter.com/timjcarden/status/1772277477424971807?s=20" target="_blank" rel="noreferrer noopener">thread&nbsp;</a>by Tim Carden has over five million views and points to several commonalities among the companies that are owned or were sold by Reynolds.
Carden said Reynolds looks for opportunities and when he makes an investment or deal he actively markets the business himself and oftentimes &#8220;becomes the face of the brand.&#8221; Reynolds also helps in the creative process of making ads about products.
&#8220;When Ryan sees a viable opportunity, he takes it,&#8221; Carden said.
An example is&nbsp;Aviation Gin,&nbsp;which Reynolds tasted and fell in love. His love for the brand led to an investment and the actor became the face of the brand. Aviation Gin was later sold to alcohol giant&nbsp;Diageo PLC&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>), netting a nice return for the actor.
&#8220;While many celebrities just pump money and sit back, Ryan is in the driver&#8217;s seat.&#8221;
Another example highlighted by Carden is the marketing company&nbsp;Maximum Effort, which has helped with ads for the Deadpool movies, which the company is co-producing with Disney. 
&#8220;Ryan knows that as an actor, his strengths are in front of a camera — and he plays to his strengths.&#8221;
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent083024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It&#8217;s Important: Carden said Reynolds knows how to perfectly capitalize on trends and use his talents after recognizing the trend.
Reynolds<a href="https://www.benzinga.com/general/entertainment/24/01/36875148/formula-one-rejects-andretti-general-motors-team-bid-what-this-could-mean-for-us-growth-esp" target="_blank" rel="noreferrer noopener">&nbsp;also invested in&nbsp;</a>a&nbsp;Liberty Media Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) Formula 1&nbsp;motor racing team, which comes as the valuation of teams in the sport is rising.
The actor also owns a soccer team and was&nbsp;<a href="https://www.benzinga.com/general/entertainment/23/05/32174242/ryan-reynolds-senators-bid-may-be-dropped-like-its-hot-as-snoop-steps-up-in-next-episode-of" target="_blank" rel="noreferrer noopener">among the bidders</a>&nbsp;for the National Hockey League&#8217;s Ottawa Senators.
&#8220;Ryan Reynolds is more than just an actor. He is also a savvy serial businessman who knows a thing or two about building a billion-dollar brand. He hunts for opportunities, gets personally involved in marketing the business, injects his personal brand, and is always on the move,&#8221; Carden said.
Along with Aviation Gin getting bought out, another Reynolds investment recently saw a buyout.&nbsp;Mint Mobile&nbsp;was purchased by&nbsp;T-Mobile US&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>).
Like Aviation Gin, Reynolds starred in ads for the company after he invested.
The ownership of Maximum Effort helps Reynolds quickly make ads for companies he invests in and for movies he stars in. The combination leads to Reynolds easily recognizable as an investor or the face of a product.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent083024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Ryan Reynolds Dominates Box Office As Deadpool While Also Building Billion Dollar Businesses

Investors interested in Beverages - Alcohol stocks are likely familiar with Kirin Holdings Co. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/knbwy#OTC">KNBWY</a>)&nbsp;and Diageo (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/deo#NYSE">DEO</a>). But which of these two stocks is more attractive to value investors? We&#39;ll need to take a closer look to find out.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Kirin Holdings Co. and Diageo are sporting Zacks Ranks of #2 (Buy) and #5 (Strong Sell), respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that KNBWY has an improving earnings outlook. But this is only part of the picture for value investors.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
KNBWY currently has a forward P/E ratio of 13.61, while DEO has a forward P/E of 18.93. We also note that KNBWY has a PEG ratio of 0.77. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company&#39;s expected EPS growth rate. DEO currently has a PEG ratio of 4.01.
Another notable valuation metric for KNBWY is its P/B ratio of 1.32. The P/B is a method of comparing a stock&#39;s market value to its book value, which is defined as total assets minus total liabilities. By comparison, DEO has a P/B of 6.19.
These metrics, and several others, help KNBWY earn a Value grade of B, while DEO has been given a Value grade of D.
KNBWY stands above DEO thanks to its solid earnings outlook, and based on these valuation figures, we also feel that KNBWY is the superior value option right now.
<a href="https://www.zacks.com/stock/news/2328403/knbwy-or-deo-which-is-the-better-value-stock-right-now?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_3-2328403">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

KNBWY

KNBWY or DEO: Which Is the Better Value Stock Right Now?

Shares of Merck &amp; Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) fell sharply during Tuesday's session after the company reported second-quarter financial results and cut its FY24 adjusted EPS <a href="https://www.benzinga.com/general/biotech/24/07/40036607/mercks-q2-earnings-revenue-and-eps-beat-helped-by-strong-keytruda-sales-but-acquisition-costs-bit">guidance below estimates</a>.
Merck reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Merck shares dipped 9.5% to $115.50 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Imunon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) shares jumped 147.8% to $2.9250 after the company announced topline results from its Phase 2 OVATION 2 study with IMNN-001. The results showed an 11.1-month improvement in median overall survival compared to standard-of-care alone in the intent-to-treat population.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) surged 97% to $0.1731. AGAPE ATP strengthened wellness division via innovative incubation with emerging local SMEs.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares climbed 53% to $2.60 after the company announced FDA clearance of its IND application for a Phase 2 clinical trial of NGC-Cap in breast cancer.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) gained 33% to $1.1513.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares gained 29% to $0.3850.</li>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) jumped 28% to $3.4018.</li>
<li>CalciMedica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) jumped 26.3% to $5.24.</li>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) rose 20.6% to $7.16 after the company reported better-than-expected second-quarter financial results.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) rose 19.1% to $2.3050.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) gained 19.1% to $146.77 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY25 revenue guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) climbed 18.8% to $13.96 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.</li>
<li>Meta Data Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIU#NYSE">AIU</a>) gained 18.8% to $5.42.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) rose 18.3% to $0.59 after jumping around 6% on Monday.</li>
<li>Inspirato Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) gained 18.3% to $6.20 after jumping over 50% on Monday.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares gained 15.9% to $98.13 after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>NeoGenomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) gained 16.1% to $17.00 following upbeat earnings.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) rose 16.1% to $2.1250 after the company reported better-than-expected quarterly financial results.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) gained 15.5% to $97.79 after the company reported better-than-expected second-quarter financial results. Additionally, the company issued third-quarter earnings guidance above estimates.</li>
<li>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) climbed 14.1% to $94.56 following better-than-expected second-quarter earnings, issued strong guidance, raised its dividend, increased its buyback authorization and issued strong guidance.</li>
<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) gained 13.4% to $156.48 following -quarter earnings.</li>
<li>Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) climbed 13.3% to $54.92 as the company reported better-than-expected second-quarter financial results and raised its FY24 guidance on Monday.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) gained 11% to $14.98 after the company reported better-than-expected second-quarter EPS results.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose 10.6% to $196.46 after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares gained 9.8% to $8.28. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) climbed 8.5% to $63.98 after the company reported better-than-expected second quarter financial results.</li>
<li>Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) rose 8.1% to $104.28 after the company reported better-than-expected second quarter financial results. Additionally, the company revised its FY24 adjusted EPS forecast upward.</li>
<li>Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) gained 6.4% to $500.83 following better-than-expected quarterly earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares fell 80.8% to $11.44. This sudden decline was triggered by the registration of two private placements with the U.S. Securities and Exchange Commission, which unlocked millions of shares and led to increased selling pressure, Bloomberg reported on Tuesday.</li>
<li>VBI Vaccines Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBIV#NASDAQ">VBIV</a>) declined 64.8% to $0.1960 after the company was granted protection under Canada&#8217;s CCAA by the Ontario Superior Court. The company received approval for a DIP loan, and Ernst &amp; Young was appointed as the monitor during the restructuring process.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) dipped 40.8% to $0.6158 after the company announced it entered into an exclusive license agreement with Cortice Biosciences.</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) tumbled 37% to $0.73.</li>
<li>Bloomz Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) dipped 30.7% to $1.78.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) fell 26.6% to $1.0901 after the company reported worse-than-expected quarterly sales results.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares declined 25.2% to $12.27 after declining 4% on Monday.</li>
<li>VSee Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEE#NASDAQ">VSEE</a>) fell 23.3% to $2.7999.</li>
<li>SmartRent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) dipped 21.5% to $1.8850 after the company announced a CEO resignation and suspended its 2024 outlook.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares fell 21.1% to $28.13 after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) fell 16.5% to $152.91 after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) fell 16.2% to $13.82. NIP Group announced the closing of its initial public offering and partial exercise of underwriters' option to purchase additional ADSs.</li>
<li>Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) dipped 16.2% to $43.68 after the company reported worse-than-expected quarterly financial results. Additionally, Raymond James downgraded the stock.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 14.2% to $32.24 after the company issued roughly in-line guidance.</li>
<li>OneWater Marine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) dipped 13.2% to $26.43 after the company reported worse-than-expected third-quarter financial results and issued weak guidance.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares fell 11.6% to $37.06 after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Transcat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) declined 11.2% to $120.00 following weak quarterly sales.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) dipped 9.7% to $233.65 following reports indicating Delta Air Lines would seek compensation from the cybersecurity company for last week&#8217;s outage.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares dipped 9.3% to $50.61 following weak quarterly sales.</li>
<li>Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) fell 8.7% to $38.99 following second-quarter results.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares fell 8.3% to $50.40 after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.</li>
<li>Ecolab Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) declined 6.7% to $231.31 after the company reported worse-than-expected second-quarter sales results.</li>
<li>The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) fell 6.2% to $159.37 following a quarterly revenue miss.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 5.5% to $124.30 after the company missed annual profit expectations.</li>
<li>Fresenius Medical Care AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) shares declined 4.5% to $19.45 following weak quarterly sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40039797/top-3-health-care-stocks-you-may-want-to-dump-this-quarter">Top 3 Health Care Stocks You May Want To Dump This Quarter</a></li>
</ul>

Intraday Update

AMKR

ATPC

BIMI

BLMZ

CALC

CLDX

CNSP

CRWD

CVLT

EKSO

ENVB

FFIV

HAYW

HLIT

IMNN

INVO

ISPO

JBLU

JTAI

LSCC

LUMN

MBIN

NIPG

NVAX

ONEW

PCSA

PHAR

PYPL

RGEN

RMBS

SMRT

TLRY

TRNS

TWOU

VBIV

VRNS

VSEE

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Tuesday.
Shares of Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected second-quarter financial results and issued weak <a href="https://www.benzinga.com/news/earnings/24/07/40022763/lattice-semiconductor-stock-falls-on-worse-than-expected-q2-results">third-quarter revenue guidance</a>.
Lattice Semiconductor reported quarterly earnings of 23 cents per share, which missed the analyst consensus estimate of 24 cents per share. Quarterly sales came in at $124.076 million, which missed the analyst consensus estimate of $130.172 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Lattice Semiconductor shares tumbled 14.8% to $46.82 in the pre-market trading session.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares dipped 19.5% to $28.70 in pre-market trading after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) declined 10.5% to $164.01 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares dipped 9.6% to $14.85 in pre-market trading after declining 4% on Monday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares tumbled 8.6% to $38.33 in pre-market trading after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) declined 8.5% to $120.36 in pre-market trading after the company missed annual profit expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares fell 7.8% to $51.50 in pre-market trading following weak quarterly sales.</li>
<li>Soho House &amp; Co Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHCO#NYSE">SHCO</a>) fell 7.3% to $4.80 in pre-market trading. Soho House &amp; Co will release its second-quarter financial results on Friday, Aug. 9.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) declined 6.8% to $14.67 in pre-market trading.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 6.2% to $35.28 in pre-market trading after the company issued roughly in-line guidance.</li>
<li>Fresenius Medical Care AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) shares declined 5.7% to $19.20 in pre-market trading following weak quarterly sales.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares declined 4.7% to $246.69 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40009447/roblox-morgan-stanley-and-2-other-stocks-insiders-are-selling">Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

FTEL

SHCO

Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Shares of F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings <a href="https://www.benzinga.com/news/earnings/24/07/40023356/f5-shares-climb-on-better-than-expected-q3-results-strong-forward-guidance">guidance above estimates</a>.
F5 reported quarterly earnings of $3.36 per share, which beat the analyst consensus estimate of $2.97 per share. Quarterly sales came in at $695.495 million, which beat the analyst consensus estimate of $686.062 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
F5 shares jumped 14.3% to $202.92 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Imunon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) gained 104.2% to $2.41 in pre-market trading. IMUNON will report topline results from the Phase 2 OVATION 2 study with IMNN-001 In advanced ovarian cancer on July 30.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares climbed 48% to $0.4422 in pre-market trading.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) rose 26.3% to $0.6289 in pre-market trading after jumping around 6% on Monday.</li>
<li>Inspirato Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) gained 22.3% to $6.41 in pre-market trading after jumping over 50% on Monday.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares gained 17.4% to $99.50 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) gained 16.1% to $22.51 in pre-market trading after jumping 47% on Monday.</li>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) shares gained 15.2% to $19.00 in pre-market trading. NIP Group announced the closing of its initial public offering and partial exercise of underwriters&#8217; option to purchase additional ADSs.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares gained 10.1% to $8.30 in pre-market trading. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>Nomura Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) gained 8.2% to $6.33 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares fell 79.9% to $12.00 in pre-market trading after dipping 23% on Monday.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares declined 19.5% to $28.70 in pre-market trading after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares fell 14.8% to $46.82 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.</li>
<li>TROOPS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares fell 13.2% to $3.22  in pre-market trading.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) fell 10.5% to $164.01 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares declined 9.6% to $14.85 in pre-market trading after declining 4% on Monday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares fell 8.6% to $38.33 in pre-market trading after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 8.5% to $120.36 in pre-market trading after the company missed annual profit expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares dipped 7.8% to $51.50 in pre-market trading following weak quarterly sales.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 6.2% to $35.28 in pre-market trading after the company issued roughly in-line guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40009447/roblox-morgan-stanley-and-2-other-stocks-insiders-are-selling">Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

SERV

TROO

Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Diageo plc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) famed for its Johnnie Walker whisky and Tanqueray gin, is bracing for its first yearly sales decline since 2020. The company has been under the radar following a profit warning last November, leading to a dip in investor confidence.
What Happened: Diageo&#8217;s U.S. market share has seen a downward trend. Analysts are predicting a 0.2% fall in net sales for the year ending June 30. The previous year&#8217;s net sales of Diageo were 17.1 billion pounds ($22 billion), Reuters reported on Monday.
Despite achieving almost 11 billion pounds ($14.13 billion) in sales during the first half of the year, analysts like Fintan Ryan at Goodbody Stockbrokers caution that the final result could be worse than consensus forecasts. Persistent issues in the U.S. and Latin America could result in a lower full-year delivery, Ryan noted.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39997974/anthony-scaramucci-tim-scott-weigh-in-ahead-of-ex-presidents-address-at-bitcoin-2024-confe?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Anthony Scaramucci, Tim Scott Weigh In Ahead Of Ex-President&#8217;s Address At Bitcoin 2024 Conference: &#8216;Trump&#8217;s Move To Court Bitcoin And Towards Crypto Assets Has Shaken The Democrats At Core&#8217;</a>
Diageo&#8217;s recent struggles mirror the broader challenges the spirits industry is facing, as demand has dropped following a post-pandemic sales boom. Investors are eager to see Diageo reclaim its market share in North America, which contributes to 40% of its sales.
Moreover, Diageo has cautioned of a potential 10-20% sales drop in Latin America and the Caribbean. The company was taken by surprise by the build-up of unsold stock among wholesalers and retailers in Mexico during the first half of the year.
Why It Matters: Earlier this year, Diageo&#8217;s shares took a hit, <a href="https://www.benzinga.com/markets/equities/24/01/36840057/johnnie-walker-maker-diageo-tanks-after-missing-estimates-latin-america-woes-deepen">dropping over 3%</a> after the company reported a decline in organic net sales, missing analyst estimates. The spirits giant also warned of further challenges in Latin America, where unsold stock accumulates.
Adding to the company&#8217;s woes, American rapper Sean "Diddy" Combs and Diageo ended their <a href="https://www.benzinga.com/general/entertainment/24/01/36657562/rapper-diddy-and-diageo-part-ways-a-look-at-the-high-stakes-split-in-the-beverage-industry">long-standing partnership</a> on Cîroc vodka and DeLeón tequila earlier this year. The split followed a legal dispute in which Combs sued Diageo, alleging the company neglected the DeLeón brand in favor of its other tequila labels.
Price Action: Diageo closed at $132.43 on Friday, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39970069/investors-go-all-in-on-small-caps-pour-over-6-billion-into-russell-2000-etf-this-month-they-will?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Investors Go All In On Small Caps, Pour Over $6 Billion Into Russell 2000 ETF This Month: They &#8216;Will Return To Larger-Cap Alternatives,&#8217; Veteran Analyst Says</a></li>
</ul>
Image by pil76 via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Johnnie Walker Maker Diageo Faces First Annual Sales Decline Since 2020 Amid Investor Concerns And Profit Warning

Legal

New Delhi City Police Summons Diageo India CEO To Appear At Investigation Into Case Linked To Payments By Government Agencies For Liquor Purchases

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Boeing (BA) provided a downbeat Q4 pre...

Boeing provides downbeat pre-announcement, Verizon reports Q4 beat: Morning Buzz

Diageo pours cold water on report of Guinness sale

Diageo (DEO) released a statement saying, "We note the recent media speculation around the Guinness brand and our stake in Moet Hennessy (LVMUY) an...

Diageo says it has no plans to sell Guinness brand, Moet Hennessy stake

Wall Street Brunch: Sparks Could Fly At Fed Presser

UBS analyst Sanjeet Aujla maintained a Buy rating on Diageo (DGEAF – Research Report) today and set a price target of p2,920.00. The company's shar...

UBS Sticks to Their Buy Rating for Diageo (DGEAF)

Diageo PLC ($DEO) has dismissed rumors about the potential spin-off or sale of its beer brand, Guinness. The company put media speculation to rest ...

Diageo Shuts Down Guinness Sale Rumors

Brewer Diageo ($DEO) has agreed to sell its 80.4% stake in Guinness Ghana to France's Castel Group for $81 million. Diageo said that it would conti...

Alcohol Giant Diageo (DEO) Sells Stake in Guinness Ghana for $81 Million

In a report released today, Simon Hales from Citi maintained a Buy rating on Diageo (DGEAF – Research Report), with a price target of £29.00. The c...

Citi Reaffirms Their Buy Rating on Diageo (DGEAF)

RGA Investment Advisors Q4 2024 Investment Commentary

Diageo: An Incredibly Compelling Combination Of Growth, Cash Flow, And Yield

AAPL

AMZN

AVGO

COST

CRZBY

DGEAF

ERIC

GOOG

GOOGL

ISRG

LKFN

LVMHF

LVMUY

MIDD

MSFT

NFLX

NVDA

PLTR

SFTBF

SFTBY

TSLA

TWLO

UBER

UBSI

Press Releases

TANQUERAY LONDON DRY GIN LAUNCHES 'CLASSIC OR NOTHING' CAMPAIGN: A BOLD DECLARATION THAT CELEBRATES THE ENDURING INFLUENCE OF TIME-HONORED CLASSICS AND THE LEGENDS THAT CHOOSE THEM

CROWN ROYAL UNVEILS GAME PLAN TO HONOUR CANADA'S UNSUNG HOCKEY BEAUTIES WITH NEW CUJO CAMPAIGN AND YEAR-LONG BARDOWN POWER PLAY

Diageo identifies 2025 socialising trends in new global report

Kentucky Distilleries and Precision Conservation Management Join Forces to Enhance Regenerative Corn Farming Practices throughout Commonwealth

CAPTAIN MORGAN & T-PAIN SET SAIL IN THE BIG EASY FOR THE BIG GAME, TRANSFORMING BOURBON STREET INTO 'RUM STREET' FOR SUPER BOWL LIX

CÎROC Ultra-Premium Vodka Opens Applications for Inaugural Blue Dot Creative Residency in Park City During Festival Week

POPEYES® AND TEQUILA DON JULIO LAUNCH "THE CHAMPIONSHIP LINEUP" - A LIMITED EDITION MENU FOR FOOTBALL'S BIG GAME

CROWN ROYAL HONORS NEW ORLEANS WITH LIMITED-EDITION STARTER SUPER BOWL LIX SATIN JACKET INSPIRED BY THE HISTORIC CITY

JOHNNIE WALKER BLENDED SCOTCH WHISKY AND RONNY CHIENG CELEBRATE LUNAR NEW YEAR, HONORING TRADITIONS WHILE MAKING THEM YOUR OWN FOR A MEMORABLE CELEBRATION

Diageo North America Announces New Manufacturing and Warehousing Facility in Alabama

Comments

Diageo

매도 수량

Diageo (NYSE:DEO) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌